Table 1.

Baseline Characteristics in Patients with AMI.

	Male (n = 220)	Female (n = 61)	P value
Cardiovascular risk factors
Age [years ($\overline{\mathrm{x}}$ ± s)]	58.53 ± 12.83	68.64 ± 8.97	<0.001
Hypertension [n (%)]	41 (18.64)	28 (45.90)	<0.001
Diabetes mellitus [n (%)]	63 (28.64)	28 (45.90)	0.011
Current smoking [n (%)]	162 (73.64)	4 (7.56)	<0.001
BMI [Kg/m2 ($\overline{\mathrm{x}}$ ± s)]	25.62 ± 3.50	24.87 ± 3.75	0.155
Obesity [n (%)]	41 (18.64)	13 (21.31)	0.639
Dyslipidemia [n (%)]	120 (54.55)	31 (50.82)	0.606
Family history of CAD [n (%)]	61 (27.73)	13 (21.31)	0.314
Biomarkers
TC [mmol/l, M (Q1, Q3)]	4.30 (3.70,5.10)	4.75 (3.88,5.35)	0.045
TG [mmol/l, M (Q1, Q3)]	1.20 (0.80,1.70)	1.20 (0.80,1.90)	0.578
HDL-C [mmol/l, M (Q1, Q3)]	1.29 (1.14,1.47)	1.39 (1.25,1.62)	0.007
LDL-C [mmol/l, M (Q1, Q3)]	2.48 (1.94,3.13)	2.57 (2.08,3.23)	0.236
Glucose [mmol/l, M (Q1, Q3)]	6.58 (5.06,8.71)	7.1 (5.70,10.30)	0.060
HbA1c [%, M (Q1, Q3)]	6.00 (5.55,7.00)	6.50 (5.80,7.60)	0.015
Hs-CRP [mg/L, M (Q1, Q3)]	1.96 (0.73,5.90)	2.17 (0.67,6.20)	0.973
Uric acid [umol/L, M (Q1, Q3)]	332.5 (270.8, 399.5)	299 (238, 337)	0.001
Hcy [umol/L, M (Q1, Q3)]	12.30 (10.35,16.25)	9.60 (7.70,12.83)	<0.001
BNP [pg/ml, M (Q1, Q3)]	276 (117,754)	596 (184.5,1755)	0.002
Prior drug treatment
Statin [n (%)]	42 (19.09)	11 (18.03)	0.852
Aspirin [n (%)]	23 (10.45)	7 (11.48)	0.819
Beta-blocker [n (%)]	13 (5.91)	4 (6.56)	0.851
CCB [n (%)]	42 (19.09)	24 (39.34)	0.001
ACEI/ARB [n (%)]	33 (15.00)	12 (19.67)	0.379
Coronary severity scores
SYNTAX score	15 (9,21.5)	13.5 (8,19.5)	0.286

BMI, body mass index; TC, total cholesterol; TG, total triglyceride; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; HbA1c, glycosylated hemoglobin A; Hs-CRP, high-sensitive-C-reactive-protein; Hcy, homocysteic acid; BNP, B-type natriuretic peptide; CCB, calcium-channel blocker; ACEI, angiotensin converting enzyme inhibitor; ARB, angiotensin receptor blocker.